A Phase 3, Randomized, Double-Blinded, Placebo-Controlled Study of ARQ 197 Plus Erlotinib Versus Placebo Plus Erlotinib

Clinical trial NCT01377376 · TERMINATED

Trial details

NCT number: NCT01377376
Sponsor: Kyowa Kirin Co., Ltd.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Non-small-cell Lung Cancer

Start date: 2011-07-01
Primary completion: 2015-11-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.